Interaction between Alzheimer's Aβ(25-35) peptide and phospholipid bilayers: The role of cholesterol

被引:59
|
作者
D'Errico, Gerardino [1 ]
Vitiello, Giuseppe [1 ]
Ortona, Ornella [1 ]
Tedeschi, Annamaria [2 ]
Ramunno, Anna [2 ]
D'Ursi, Anna Maria [2 ]
机构
[1] Univ Naples Federico 2, Dipartimento Chim Paolo Corradini, I-80126 Naples, Italy
[2] Univ Salerno, Dipartimento Sci Farmaceut, Fisciano, Italy
来源
关键词
Alzheimer disease; Amyloid peptides; Phospholipids; Cholesterol; Electron paramagnetic resonance;
D O I
10.1016/j.bbamem.2008.07.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is mounting evidence that the lipid matrix of neuronal cell membranes plays an important role in the accumulation of beta-amyloid peptides into senile plaques, one of the hallmarks of Alzheimer's disease (AD). With the aim to clarify the molecular basis of the interaction between amyloid peptides and cellular membranes, we investigated the interaction between a cytotoxic fragment of A beta(1-42), i.e., A beta(25-35), and phospholipid bilayer membranes. These systems were studied by Electron Paramagnetic Resonance (EPR) spectroscopy, using phospholipids spin-labeled on the acyl chain. The effect of inclusion of charged phospholipids or/and cholesterol in the bilayer composition was considered in relation to the peptide/membrane interaction. The results show that A beta(25-35) inserts in bilayers formed by the zwitterionic phospholipid dilauroyl phosphatidylcholine (DLPC), positioning between the outer part of the hydrophobic core and the external hydrophilic layer. This process is not significantly influenced by the inclusion of the anionic phospholipid phosphatidylglycerol (DLPG) in the bilayer, indicating the peptide insertion to be driven by hydrophobic rather than electrostatic interactions. Cholesterol plays a fundamental role in regulating the peptide/membrane association. inducing a membrane transition from a fluid-disordered to a fluid-ordered phase. At low cholesterol content, in the fluid-disordered phase, the insertion of the peptide in the membrane causes a displacement of cholesterol towards the more external part of the membrane. The crowding of cholesterol enhances its rigidifying effect on this region of the bilayer. Finally, the cholesterol-rich fluid-ordered membrane looses the ability to include A beta(25-35). (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:2710 / 2716
页数:7
相关论文
共 50 条
  • [31] Anti-apoptotic proteins are oxidized by Aβ25-35 in Alzheimer's fibroblasts
    Choi, J
    Malakowsky, CA
    Talent, JM
    Conrad, CC
    Carroll, CA
    Weintraub, ST
    Gracy, RW
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1637 (02): : 135 - 141
  • [32] Spectroscopic investigation of Ginkgo biloba terpene trilactones and their interaction with amyloid peptide Aβ(25-35)
    He, Jiangtao
    Petrovic, Ana G.
    Dzyuba, Sergei V.
    Berova, Nina
    Nakanishi, Koji
    Polavarapu, Prasad L.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2008, 69 (04) : 1213 - 1222
  • [33] Autoimmune responses to amyloid structures of Aβ(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease
    Grudena, MA
    Davudova, TB
    Malisauskas, M
    Zamotin, VV
    Sewell, RDE
    Voskresenskaya, NI
    Kostanyan, IA
    Shrestnev, VV
    Morozova-Roche, LA
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (02) : 165 - 171
  • [34] Structural diversity of dimers of the Alzheimer amyloid-β(25-35) peptide and polymorphism of the resulting fibrils
    Wei, Guanghong
    Jewett, Andrew I.
    Shea, Joan-Emma
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2010, 12 (14) : 3622 - 3629
  • [35] Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease
    Lee, Young Woo
    Kim, Dong Hyun
    Jeon, Su Jin
    Park, Se Jin
    Kim, Jong Min
    Jung, Jun Man
    Lee, Hyung Eun
    Bae, Shin Gil
    Oh, Hee Kyong
    Son, Kun Ho Ho
    Ryu, Jong Hoon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 704 (1-3) : 70 - 77
  • [36] Coinjection of amyloid β peptide(25-35) and ibotenic acid does not create an animal model for Alzheimer's disease.
    Laksafoss, T
    Jorgensen, OS
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 93 - 93
  • [37] Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions
    Waiter, MF
    Mason, PE
    Mason, RP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (03) : 760 - 764
  • [38] Electrophysiologic properties of channels induced by Aβ25-35 in planar lipid bilayers
    Lin, MCA
    Kagan, BL
    PEPTIDES, 2002, 23 (07) : 1215 - 1228
  • [39] Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Aβ25-35 to erythrocytes
    Kosenko, E. A.
    Solomadin, I. N.
    Marov, N. V.
    Venediktova, N. I.
    Poghosyan, A. S.
    Kaminsky, Yu. G.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2008, 34 (05) : 586 - 592
  • [40] PHOSPHATIDYL-CHOLESTEROL BILAYERS - A MODEL FOR PHOSPHOLIPID-CHOLESTEROL INTERACTION
    JAIN, MK
    RAMIREZ, F
    MCCAFFREY, TM
    IOANNOU, PV
    MARECEK, JF
    LEUNISSENBIJVELT, J
    BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 600 (03) : 678 - 688